Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference
Although vaccination has been an effective way of preventing infections ever since the eighteenth century, the generation of therapeutic vaccines and immunotherapies is still a work in progress. A number of challenges impede the development of these therapeutic approaches such as safety issues relat...
Main Authors: | Karine Chartrand, Marie-Ève Lebel, Esther Tarrab, Pierre Savard, Denis Leclerc, Alain Lamarre |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01885/full |
Similar Items
-
Development and Validation of a Multiplex Reverse Transcription PCR Assay for Simultaneous Detection of Three Papaya Viruses
by: Decai Tuo, et al.
Published: (2014-10-01) -
Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity
by: Marie-Eve Laliberté-Gagné, et al.
Published: (2021-01-01) -
Plasmacytoid dendritic cells in atherosclerosis
by: Yvonne eDöring, et al.
Published: (2012-06-01) -
Overexpression of miR-223 Promotes Tolerogenic Properties of Dendritic Cells Involved in Heart Transplantation Tolerance by Targeting Irak1
by: Shun Yuan, et al.
Published: (2021-08-01) -
Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?
by: Peter H. Liu, et al.
Published: (2019-11-01)